戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  to insure that the prevention is not merely cosmetic.
2 nce of this expectation, surgery was labeled cosmetic.
3 tion for possible use in pharmaceuticals and cosmetics.
4 h, it is an essential target in medicine and cosmetics.
5 ssing, enzyme reactions, pharmaceuticals and cosmetics.
6  molecules also occur in pharmaceuticals and cosmetics.
7 re widely used as invisible UV protectant in cosmetics.
8 for industries like food, pharmaceutical and cosmetics.
9 medications, potentially toxic chemicals and cosmetics.
10 d in vitamin supplements, feed additives and cosmetics.
11 and sensitive sensors for quality control in cosmetics.
12 , a common ingredient in sunscreen and other cosmetics.
13 nteresting raw material in the production of cosmetics.
14 ducts, including plastics, epoxy resins, and cosmetics.
15 logy, molecular biology, drug discovery, and cosmetics.
16 taining products such as pharmaceuticals and cosmetics.
17              Although the primary benefit is cosmetic, (a single incision predominantly contained wit
18  requirements of the Federal Food, Drug, and Cosmetic Act.
19 nvasive surgery is safe, with the additional cosmetic advantage and convenience for the willing donor
20 es; however there is an inherent and obvious cosmetic advantage to the laparoscopic and circumumbilic
21 erter-defibrillator may offer procedural and cosmetic advantages.
22 ot only for biomedical purposes but also for cosmetics, agriculture and electronics.
23     Women who used shampoo, conditioner, and cosmetics also showed 70-80% higher BP concentrations in
24 purposes but have been used recently for the cosmetic alteration of eye colour.
25         We caution against their use for the cosmetic alteration of eye colour.
26                      After a planned interim cosmetic analysis, the data, safety, and monitoring comm
27  RCT reporting superior short- and long-term cosmetic and body image, postoperative pain, and QoL in
28 ir use is restricted, particularly for food, cosmetic and drug manufacture, due to the extremely toxi
29                           Although there are cosmetic and economical advantages to the VATS approach,
30 ions in the pharmaceutical, food processing, cosmetic and fine chemical industries.
31 ients in drugs, they are also widely used as cosmetic and food additives.
32 pensions, commonplace in the pharmaceutical, cosmetic and food industries, display intriguing rheolog
33 n present for surgical management because of cosmetic and functional concerns.
34 information, high cure rates, and acceptable cosmetic and functional outcomes.
35 CC without bone involvement, with satisfying cosmetic and functional outcomes.
36  postburn hypermetabolism, and the long-term cosmetic and functional results have not yet been evalua
37       Most patients were very satisfied with cosmetic and global outcomes of the surgery.
38 plants following enucleation allow excellent cosmetic and motility outcome.
39 nefits of improved patient satisfaction with cosmetic and overall outcomes.
40                     Parabens may be added to cosmetic and personal care products for preservation pur
41 otential as a functional ingredient in food, cosmetic and pharmaceutical applications.
42 ctroscopy for the direct analysis of viscous cosmetic and pharmaceutical formulations such as creams,
43 reat promise for their applications in food, cosmetic and pharmaceutical industries.
44 ines can be then extracted and used in food, cosmetic and pharmaceutical industries.
45 his fruit may find applications in the food, cosmetic and pharmaceutical industries.
46 materials for several end-users in the food, cosmetic and pharmaceutical industries.
47 se as a raw material in dietary supplements, cosmetic and pharmaceutical products, or as a source of
48 ing a new breast reconstruction and may have cosmetic and quality-of-life implications for patients.
49 s have been widely studied and developed for cosmetic and therapeutic applications.
50 and protectors against oxidation in food and cosmetics and also due to their health implications, mai
51 nefit of engineered nanoparticles for use in cosmetics and as tools for understanding skin biology an
52 scaled, suggesting near-term applications in cosmetics and biomedicine.
53 cants, clothing, deodorants, sunscreens, and cosmetics and can potentially accumulate in our food sup
54 ssing and are used extensively by the foods, cosmetics and coatings industries.
55 ative of vitamin A, is a common component in cosmetics and commercial acne creams as well as being a
56 uctured encapsulation applications in foods, cosmetics and drug delivery.
57 bers or fiber composites, and development of cosmetics and drugs for hair.
58 he controlled delivery and release of cells, cosmetics and drugs, and as supports for cell growth and
59 d source of phenolic compounds to be used in cosmetics and food products.
60 d source of phenolic compounds to be used in cosmetics and food products.
61 s) are widely used as components of drugs or cosmetics and hold great promise for biomedicine, yet th
62 otential applications in industry, medicine, cosmetics and human nutrition.
63 al polymeric carriers, to the formulation of cosmetics and insecticides, to the fabrication of nanost
64  among the most widely used xenoestrogens in cosmetics and personal-care products and are generally c
65  making by-products are of interest in food, cosmetics and pharmaceutical industries.
66 nd unsaturated fatty acids in food industry, cosmetics and pharmaceutical preparations.
67 ered promising new green solvents for foods, cosmetics and pharmaceuticals due to their unique solven
68 quiterpenoid volatile flavor, used in foods, cosmetics and pharmaceuticals, possessing also insect re
69 olorants for everyday products as various as cosmetics and printing inks.
70 d butyl paraben) in different samples (food, cosmetics and water) based on isobutyl chloroformate (IB
71 rdiac surgery; reproductive care; and joint, cosmetic, and dental procedures.
72 elopment of skin products in pharmaceutical, cosmetic, and sanitary applications.
73 ons for applications in the pharmaceuticals, cosmetics, and food industries.
74 tical materials, chemical sensors, medicine, cosmetics, and food industry is presented.
75 nufacturing of pharmaceuticals, inks, foams, cosmetics, and food.
76 ccurring fatty acid widely utilized in food, cosmetics, and homeopathic supplements.
77 d as a flavouring agent in beverages, foods, cosmetics, and household products.
78  pharmaceutical, electronics, environmental, cosmetics, and hygiene industries.
79 psules for food, in chemical separations, in cosmetics, and in dynamic optics.
80 idants that are widely used in perfumery and cosmetics, and in treating disorders associated with oxi
81 ified through their widespread use in foods, cosmetics, and pharmaceutical products.
82 y sustainable photonic pigments in coatings, cosmetics, and security labeling.
83 wide variety of products including paint and cosmetics, and they are known to cause allergic contact
84  offers women an excellent option to improve cosmetic appearance and self-confidence following mastec
85 akthrough in the restoration of function and cosmetic appearance for injured patients, but the proced
86 tance-2 [MRD2]), reduction of lagophthalmos, cosmetic appearance, complications, and need for further
87 known for its use as an antiwrinkle agent in cosmetic applications (including Botox and Dysport).
88  tolerable residues, and some biomedical and cosmetic applications are exemplified.
89         Clinical reports of microneedles for cosmetic applications including acne vulgaris, acne scar
90 bset of botulinum toxins are widely used for cosmetic applications, treatment of various movement dis
91 ng peptide-based inhibitors for the food and cosmetic applications.
92 muli such as odorants that are often used in cosmetic articles.
93  active ingredients in so-called 'functional cosmetics' as well as a major role as catalysts for the
94 <0.001) and more often billed patients for a cosmetic blepharoplasty (5% before vs. 12% after, P = 0.
95                                              Cosmetic blepharoplasty with fat pad debulking should be
96 ng plastic and glass beverage, medicine, and cosmetic bottles, with no change in experimental geometr
97 iscusses the unexpected relationship between cosmetic breast implants and suicide that has been found
98 dies, the suicide rate of women who received cosmetic breast implants is approximately twice the expe
99 -than-expected suicide rate among women with cosmetic breast implants warrants further research.
100 overy of BCVA after iatrogenic RAO following cosmetic CaHA injection.
101  statistics of labelling of preservatives on cosmetics can be included, the latter two approaches all
102 effective production of nutritional food and cosmetic commodities.
103 al structure the hair follicle can result in cosmetic concerns that affect most of us.
104 inence, vaginal stenosis, clitoral pain, and cosmetic concerns; for males with classic congenital adr
105 re adverse effects can occur after extensive cosmetic conjunctival resection followed by topical mito
106 ften associated with substantial medical and cosmetic consequences.
107 a host of applications, such as electronics, cosmetics, construction, and medicine, and as a result,
108  disorders can range in severity from purely cosmetic damage to organ and/or life-threatening disease
109 sideration in this location is the potential cosmetic deformity caused by wide excision of the melano
110 ion and minimising the functional deficit or cosmetic deformity in the affected area, particularly in
111 of vital teeth has become common practice in cosmetic dentistry today.
112     Common noninvasive to minimally invasive cosmetic dermatologic procedures are widely believed to
113            Noninvasive to minimally invasive cosmetic dermatologic procedures, including energy, neur
114 reventive services and a growing emphasis on cosmetic dermatology are anticipated to exacerbate this
115     There are numerous barriers to achieving cosmetic dermatology competency during residency.
116                                 Frequency of cosmetic dermatology devices and injectables used for de
117                                 The field of cosmetic dermatology is evolving quickly, with limited s
118 idents should not be required to perform any cosmetic dermatology procedures.
119  specialties expect dermatologists who offer cosmetic dermatology services to provide competent care.
120        Only 20 of 53 (38%) PDs believed that cosmetic dermatology should be a necessary aspect of res
121 y training, categorizing PD attitudes toward cosmetic dermatology training during residency and descr
122    All but 3 programs (94%) offered hands-on cosmetic dermatology training using botulinum toxin, and
123 ables used for dermatology resident hands-on cosmetic dermatology training, categorizing PD attitudes
124 hough almost every program provides hands-on cosmetic dermatology training, there are barriers to tra
125 edures and products, and PD attitudes toward cosmetic dermatology training.
126 experts in pediatric dermatology, procedural/cosmetic dermatology, plastic surgery, scars, wound heal
127 ogy outpatient clinical practices focused on cosmetic dermatology, with a total of 23 dermatologists.
128 s that can cause significant visual loss and cosmetic disfigurement in children.
129  3.07+/-2.29 postoperatively; P < 0.001) and cosmetic disturbance (6.33+/-3.21 preoperatively vs. 1.5
130 , especially increased glare sensitivity and cosmetic disturbances.
131 eful in pharmaceuticals, food additives, and cosmetics due to its recently discovered biomedical acti
132                                              Cosmetic elegance was the most cited positive feature (1
133 matologists should balance the importance of cosmetic elegance, cost, and AAD guidelines for sun prot
134 cording to consumer comments: affordability, cosmetic elegance, separate ratings, product ingredients
135                        Physicians performing cosmetic enhancement procedures involving facial fillers
136 n biomedicine, nanotechnology, food science, cosmetics, etc.
137 agement of complications following bilateral cosmetic eye whitening.
138       Seventeen eyes of 9 patients underwent cosmetic eye-whitening performed between 2 and 48 months
139 al retinal artery occlusion occurring, after cosmetic facial enhancement, was irreversible in 3 patie
140                                              Cosmetic facial fillers are not approved for use in the
141 e investigated all workers (9) employed by a cosmetic factory and exposed to argan powder to identify
142 tential applications in imaging, therapy and cosmetics fields.
143                          Dermal injection of cosmetic fillers can lead to irreversible blindness when
144 patawa fruit as a new amazonian resource for cosmetics, food and pharmaceuticals purposes.
145 uch complex media as wines, fruit juices, or cosmetic formulation.
146 ents are commonly used in pharmaceutical and cosmetic formulations and sanitary products and cleanser
147 dants in foodstuffs, food preservatives, and cosmetics has proved to be very vital.
148 ts for personal care, generally perceived as cosmetics, have an important impact on everyday life wor
149 crobiome (e.g., antimicrobial drugs, topical cosmetic/hygienic products); improved approaches for ide
150 re widely used in food, pharmaceuticals, and cosmetics in the past decades.
151 of staghorn sumac in food, nutraceutical and cosmetic industries are suggested on the basis of the ch
152  the food, pharmaceutical, nutraceutical and cosmetic industries, are highlighted.
153 ia is extensively used in the food, drug and cosmetic industries, biocompatibility of nanoscale titan
154  a flavour component widely used in food and cosmetic industries, but is chemically unstable and degr
155 ilizers and may find application in food and cosmetic industries.
156 s in the textile, leather, printing ink, and cosmetic industries.
157 could be explored in the medicine, food, and cosmetic industries.
158 a significant impact in both the medical and cosmetic industries.
159 could have applications in food, medical and cosmetic industries.
160 asingly used in food/feed, pharmaceutical or cosmetic industries.
161 ising applications in the food, medical, and cosmetic industries.
162 mportant oil in the food, pharmaceutical and cosmetic industries.
163 e been seldom used in the pharmaceutical and cosmetics industries for preservative efficacy testing (
164  their application in the pharmaceutical and cosmetics industries has been limited.
165  be explored in the pharmaceutical, food and cosmetics industries.
166 logical disorders and its growing use in the cosmetic industry have also increased interest in develo
167 numerous applications, including many in the cosmetic industry.
168 ustry, as well as for nutraceuticals and the cosmetic industry.
169 ruit oils, which are commonly applied in the cosmetic industry.
170  aspects of using immobilised lipases in the cosmetics industry is given.
171  Lauraceae used in food and drugs and in the cosmetics industry.
172 1.2 ppt, which is in the range needed by the cosmetics industry.
173 ions, which might serve as potential food or cosmetic ingredients.
174                                              Cosmetic injection of calcium hydroxylapatite to the nos
175 tissue infections attributable to unlicensed cosmetic injections and the first report using multilocu
176 potential application in pharmaceuticals and cosmetics is severely compromised.
177  range of applications including pigment and cosmetic manufacturing.
178 his enzymatic protein could be used in food, cosmetic or pharmaceutical industries.
179 oactive ingredients for its use in the food, cosmetic or pharmaceutical sector.
180 ty screening and safety assessment of drugs, cosmetic or their specific ingredients.
181  unnecessary biopsies, possibly resulting in cosmetic or, more rarely, functional adverse effects, an
182 tive source of bioactive compounds for food, cosmetic, or pharmaceutical applications.
183 diagnostics, agriculture, the food industry, cosmetics, or spills of liquids.
184                                              Cosmetic outcome and patient satisfaction did not show a
185 gthier courses in terms of tumor control and cosmetic outcome and to provide an opportunity for cost
186  lack of proper informed consent (n = 5) and cosmetic outcome issues (n = 4).
187 a delay of or failure in diagnosis (n = 16), cosmetic outcome issues (n = 8), lack of informed consen
188 hiny metallic appearance, however, makes the cosmetic outcome less favorable.
189                                         Good cosmetic outcome was obtained in 84% to 89% of patients.
190 ntial to decrease re-excision rates, improve cosmetic outcome, and decrease health care costs.
191 ded SSI incidence at 4 days, length of stay, cosmetic outcome, and patient satisfaction.
192 the focus of BCT has increasingly shifted to cosmetic outcome, quality of life, and patient satisfact
193 photographs were reviewed for functional and cosmetic outcome.
194 should take into account both functional and cosmetic outcome.
195 bit and adjacent structures with outstanding cosmetic outcome.
196 econstruction would yield the best long-term cosmetic outcome.
197 ingle-port patients were more satisfied with cosmetic outcomes (P < 0.01) and the overall donation pr
198  partial-breast reconstruction have improved cosmetic outcomes after breast-conservation surgery.
199 ht to evaluate long-term quality of life and cosmetic outcomes after different locoregional managemen
200 therapy and early disease intervention, good cosmetic outcomes may be achievable, particularly in loc
201  (OPBS) were to evaluate the oncological and cosmetic outcomes of OPBS.
202 ications without compromising oncological or cosmetic outcomes of the reconstructed breast is an impo
203 use of adhesive strips as a means to improve cosmetic outcomes or reduce scar width.
204 patterns and correlates of satisfaction with cosmetic outcomes overall and, more specifically, within
205 ntial to decrease re-excision rates, improve cosmetic outcomes, and decrease health care costs.
206 ntial to decrease re-excision rates, improve cosmetic outcomes, and decrease health care costs.
207 us management with traditional therapy, poor cosmetic outcomes, restricted motion, and symptoms such
208   The purse-string suture results in similar cosmetic outcomes, scar sizes, and pain levels compared
209 was noted between groups in patient-assessed cosmetic outcomes.
210 ess and treat facial volume loss to optimize cosmetic outcomes.
211 olume augmentation, or inflation, to improve cosmetic outcomes.
212 igate the deleterious impact of radiation on cosmetic outcomes.
213 dustrial applications including agriculture, cosmetics, packaging and pharmaceuticals.
214 reen (BP-3), lotion (BP-3 and parabens), and cosmetics (parabens).
215 arch, and quality improvement to incorporate cosmetic patients' perspective in outcome assessments.
216 s and asthma-related chemicals in a range of cosmetics, personal care products, cleaners, sunscreens,
217 egation to create novel structures in foods, cosmetics, personal care, and other products.
218 -products and encourage their application in cosmetic, pharmaceutical and food processing industries,
219 dology is applicable to other domains (food, cosmetic, pharmaceutical, biomedical).
220 ties that are important to the agricultural, cosmetic, pharmaceutical, food and nutraceutical industr
221 ndustrial sectors including materials, food, cosmetics, pharmaceutical among others employing colloid
222                   Since many kinds of foods, cosmetics, pharmaceutical products, and medication conta
223 , consequently, to enlarge its use in foods, cosmetics, pharmaceuticals and agrochemicals preparation
224 of p-hydroxybenzoic acid) are widely used in cosmetics, pharmaceuticals, and foodstuffs as broad-spec
225 acid and are widely used as preservatives in cosmetics, pharmaceuticals, foodstuffs, including bevera
226 anomaterials when using nanotechnology-based cosmetic powders and compare them with analogous product
227        We realistically simulated the use of cosmetic powders by applying them to the face of a human
228                                           In cosmetic practices, various cosmeceuticals are applied b
229 mical used in pharmaceutical, alimentary and cosmetic preparations.
230 used as additive in food, pharmaceutical and cosmetic preparations.
231 mphipathic compounds widely used as food and cosmetics preservatives, but the mechanisms of their bro
232 associated with orthodontic appliances are a cosmetic problem and increase risk for cavities.
233                  IH causes severe health and cosmetic problems, and its repair increases health care
234  injection for face augmentation is a common cosmetic procedure in the last decades, in our case repo
235                                              Cosmetic procedures are being performed with increased f
236 g this condition is important, especially as cosmetic procedures become more widespread.
237 ses and are popular alternatives to invasive cosmetic procedures for antiaging.
238 c Plastic Surgery statistics show outpatient cosmetic procedures increased from 3 to 11 million (1997
239  Millions of surgical and minimally invasive cosmetic procedures of the face are performed each year,
240 ients seeking surgical or minimally invasive cosmetic procedures of the face.
241 ion and reduction are two of the most common cosmetic procedures performed and knowledge of their inf
242                                The number of cosmetic procedures will continue to grow exponentially
243 his review serves as an overview of selected cosmetic procedures with pediatric applications.
244     Despite the dramatic rise in nonsurgical cosmetic procedures, there is a paucity of information r
245 s represented a consecutive sample of 20 399 cosmetic procedures.
246 to fillers in 3 patients shortly after their cosmetic procedures.
247  rates, have limited utility when applied to cosmetic procedures.
248 considered in patients with sepsis following cosmetic procedures.
249 data are needed to determine the efficacy of cosmetic procedures.
250 ts and manicurists, who are exposed daily to cosmetic products containing known or suspected human ca
251                    HQ is also widely used in cosmetic products for skin whitening.
252 f synthetic and natural retinoids in topical cosmetic products is important, and their presence can b
253          Argan is used worldwide in numerous cosmetic products, as this fruit is supposed to have man
254 tiate their application in food matrices and cosmetic products.
255 ll banned all plastic microbeads in selected cosmetic products.
256 olonged use of eye make- up and other facial cosmetic products.
257 arth's surface and is also commonly used for cosmetic purposes, is genotoxic.
258 n to have undergone episcleral tattooing for cosmetic purposes.
259 r omission of reconstruction, which can have cosmetic, quality-of-life, and complication implications
260                                          The cosmetic result was satisfactory in all cases.
261 res specified a priori were lesion response, cosmetic results, and patient satisfaction after the int
262 d offers surgeons a powerful tool to improve cosmetic results.
263 arity throughout follow-up with satisfactory cosmetic results.
264 esented with prolonged facial erosions after cosmetic resurfacing procedures, specifically fully abla
265                                        After cosmetic resurfacing, patients may develop EPD isolated
266 the ASA became the American Trudeau Society, cosmetic revisions having no effect on either the medica
267                                              Cosmetics safety should be assessed not only by the pres
268 particles in wastewater, human sera and some cosmetic samples without any cross-reactivity.
269 nanoparticles in wastewater, human sera, and cosmetic samples.
270                             Patient-reported cosmetic satisfaction was similar after breast conservat
271                                              Cosmetic satisfaction was similar between those receivin
272                                  Overall and cosmetic satisfaction, QOL as determined by the SF-36 su
273 ne versus 17.8 (17.1-18.4) at 12 months, and cosmetic scale mean scores were 17.6 (16.6-18.6) versus
274 osmesis was defined as a fair or poor global cosmetic score.
275 ents enter the workforce planning to provide cosmetic services.
276 n providing other sumptuary goods: pigments, cosmetics, slate, greenstone, travertine, and foreign po
277                                              Cosmetics, soaps and cleansers (including wet wipes), an
278  a spectrum of signs and symptoms, including cosmetic spider veins, asymptomatic varicosities, large
279 particles in consumer products, for example, cosmetics, sunscreens, and electrical devices, has incre
280 g malignancy in women, a personal history of cosmetic surgery in those undergoing treatment for breas
281 ing adverse reactions to gel fillers used in cosmetic surgery is not known.
282                                              Cosmetic surgery procedures increase in incidence annual
283 n a host of surgical procedures ranging from cosmetic surgery to cancer resection.
284 is time, the most viable treatment option is cosmetic surgery with synthetic fillers.
285 osocial domains may improve following facial cosmetic surgery, although the quality of this evidence
286 , including Bio-Alcamid touch-up treatments, cosmetic surgery, facial trauma, and dental work.
287  in the presence of polyacrylamide filler in cosmetic surgery, possibly due to a biofilm mode of grow
288 n that of women who underwent other forms of cosmetic surgery, the largest and most recent investigat
289 als to develop evidence-based anesthesia for cosmetic surgery.
290 ery to chemical and biological catalysis and cosmetics, the need for efficient fabrication pathways f
291 med using microneedle-based technologies for cosmetic, therapeutic and diagnostic applications.
292  range of consumer products including soaps, cosmetics, therapeutics, and plastics.
293             Items considered to be luxury or cosmetic (Tier 3) would generally not be covered, as is
294 the industrial sector (health, nutrition and cosmetic) to discover new biomolecules with various phys
295 mprove the design of both pharmaceutical and cosmetic topical products.
296 ver, the measurement of PhIP in dyed hair, a cosmetic treatment commonly used by the adult population
297 plants were removed from the U.S. market for cosmetic use in 1992 owing to safety concerns.
298 ear promising, the multitude of clinical and cosmetic uses of BoNT make mass vaccination against the
299 ts roles in camouflage, heat regulation, and cosmetic variation, melanin protects against UV radiatio
300  lubricants, detergents, pharmaceuticals and cosmetics while medium chain fatty alcohols (C6-C12) cou

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top